552 related articles for article (PubMed ID: 3978872)
21. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
[TBL] [Abstract][Full Text] [Related]
22. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
Stojan B
Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
[TBL] [Abstract][Full Text] [Related]
23. Complement-activating rheumatoid-factor-containing complexes in patients with rheumatoid vasculitis.
Elson CJ; Scott DG; Blake DR; Bacon PA; Holt PD
Ann Rheum Dis; 1983 Apr; 42(2):147-50. PubMed ID: 6601932
[TBL] [Abstract][Full Text] [Related]
24. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
25. Complexed rheumatoid factor measurements in sera, synovial fluids and in immune complex fractions.
Falus A; Merétey K; Böhm U; Bozsóky S
Experientia; 1979 Mar; 35(3):413-4. PubMed ID: 36289
[TBL] [Abstract][Full Text] [Related]
26. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
Böhm U; Merétey K; Falus A; Jancsó A; Bozsóky S
Allerg Immunol (Leipz); 1978; 24(3):167-74. PubMed ID: 152571
[TBL] [Abstract][Full Text] [Related]
27. A study of complement fixation by rheumatoid factor using a haemolytic assay system.
Taylor-Upsahl MM; Johnson PM; Mellbye OJ; Natvig JB
Clin Exp Immunol; 1977 May; 28(2):204-11. PubMed ID: 872448
[TBL] [Abstract][Full Text] [Related]
28. [The clinical significance of synovial fluid examination].
Yu MX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Aug; 11(4):274-7. PubMed ID: 2532973
[TBL] [Abstract][Full Text] [Related]
29. Rheumatoid synovitis: complement and immune complexes.
Schur PH; Britton MC; Franco AE; Corson JM; Sosman JL; Ruddy S
Rheumatology; 1975; 6():34-42. PubMed ID: 1202605
[TBL] [Abstract][Full Text] [Related]
30. Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.
Zubler RH; Nydegger U; Perrin LH; Fehr K; McCormick J; Lambert PH; Miescher PA
J Clin Invest; 1976 May; 57(5):1308-19. PubMed ID: 944196
[TBL] [Abstract][Full Text] [Related]
31. Rheumatoid factors bind beta 2 microglobulin. Detection of beta 2 microglobulin-complexes in rheumatoid arthritis.
Falus A; Merétey K; Böhm U; Bozsóky S
Arch Immunol Ther Exp (Warsz); 1979; 27(5):647-54. PubMed ID: 94990
[TBL] [Abstract][Full Text] [Related]
32. [Changes in the synovial membrane in early diagnosed cases of rheumatoid arthritis. II. Immunohistochemical and serological studies].
Emmrich J; Geiler G
Z Rheumatol; 1980; 39(5-6):157-69. PubMed ID: 7415585
[TBL] [Abstract][Full Text] [Related]
33. Circulating immune complexes and complement in rheumatoid arthritis.
Duquesnoy B
Ann Biol Clin (Paris); 1984; 42(1):71-5. PubMed ID: 6375473
[TBL] [Abstract][Full Text] [Related]
34. Complement-fixing material in ther sera of patients with rheumatoid arthritis.
McDuffie FC; Hunder GG; Clark RJ
Clin Exp Immunol; 1978 May; 32(2):218-25. PubMed ID: 668197
[TBL] [Abstract][Full Text] [Related]
35. [Study of the mechanism of the fall in complement levels in the synovial fluid in rheumatoid arthritis. II. Demonstration of an abnormal anti-complement property in rheumatoid synovial fluids].
Peltier AP; Vial MC; Leroy C; de Sèze S
Pathol Biol (Paris); 1970 Nov; 18(21):969-74. PubMed ID: 4099022
[No Abstract] [Full Text] [Related]
36. Enhancement of Clq binding activity by IgM rheumatoid factor.
Zilberfarb JL; Andrews BS; Young AC; Davis JS
J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
[TBL] [Abstract][Full Text] [Related]
37. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
[TBL] [Abstract][Full Text] [Related]
38. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid.
Lamour A; Baron D; Soubrane C; Cartron J; Khayat D; Adler Y; Le Goff P; Youinou P
J Autoimmun; 1995 Apr; 8(2):249-65. PubMed ID: 7612151
[TBL] [Abstract][Full Text] [Related]
39. Reduced Fc-receptor bearing cells in peripheral bloods of patients with systemic lupus erythematosus and in rheumatoid synovial fluids.
Nakai H; Morito T; Tanimoto K; Horiuchi Y
J Rheumatol; 1977; 4(4):405-13. PubMed ID: 415139
[TBL] [Abstract][Full Text] [Related]
40. Binding capacity of sera from systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) to C3c. Evaluation by enzyme linked immunosorbent assay (ELISA).
Bringuier JP; Veysseyre CM; Martin C; Raffin T; Monier JC
Pathol Biol (Paris); 1984 Dec; 32(10):1029-32. PubMed ID: 6514386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
